Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial

BACKGROUND: This study aimed to assess the efficacy of topiramate, a glutamate-modulating agent, in patients with treatment-resistant obsessive-compulsive disorder (OCD) as an adjunct to serotonin reuptake inhibitors (SRIs). MATERIALS AND METHODS: Thirty-eight patients with refractory OCD, were rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar, Hamid, Akuchekian, Shahla, Mahaky, Behzad, Zarean, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274576/
https://www.ncbi.nlm.nih.gov/pubmed/25538783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274576/
https://www.ncbi.nlm.nih.gov/pubmed/25538783

Ejemplares similares